CD44 and cancer: In contrast, primary tissue-derived human CD44+ EpCAM+ ALDH1high ERα− cancer stem cells showed an abrogation by mTOR inhibitors during combination treatment with tamoxifen, which failed to prevent sphere formation alone until an mTOR inhibitor was introduced alongside it [47].